About
Technology
Issues
FAQ
Links
Official Page
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.